Tomi Environmental Solutions, Inc. · NASDAQ:TOMZ
Tomi Environmental Solutions — Q1 2026 Earnings Presentation
33 slides from Tomi Environmental Solutions's earnings presentation, May 8, 2026
Slide 1: BIT Solution Cold Plasma System
[“]—+— €) —+— BIT SOLUTION COLD PLASMA SYSTEM NASDAQ : TOMZ | Investor Presentation 2026
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS Forward-Looking Statements This presentation contains statements that are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that a
Slide 3: Vision & Value Proposition
VISION & VALUE PROPOSITION Faster • Safer • Eco-friendly Revolutionizing cleaning & disinfection by providing a disruptive, easier, and safer way to disinfect. SPEED SAFETY EFFICACY Rapid 5 sec/ft2 surface No residue; oxygen & Six-log kill; bacterial spores, treatment humidity by-products bacteria,
Slide 4: Premier Clients, Growing Momentum, & Sustainable Growth
PREMIER CLIENTS, GROWING MOMENTUM, & SUSTAINABLE GROWTH Each new customer adds value. A growing set of referrals from premier clients is accelerating the pipeline. Expansion opportunities within existing accounts. New Product and Service offerings were shaped by premier client needs and reference fe
Slide 5: SteraMist iHP Technology
STERAMIST iHP TECHNOLOGY HYDROGEN PEROXIDE HYDROXYL CELLULAR NO WIPE, NO RINSE PARTICLES RADICALS OXIDATIVE BURSTS Quick dry; no preconditioning PORTABLE & SCALABLE From handheld to integrated systems NASDAQ : TOMZ | Investor Presentation 2026
Slide 6: Developed by DARPA for Neutralization of Weaponized Anthrax
Developed by DARPA for neutralization of weaponized anthrax. TOMI acquired patent rights and expanded registrations worldwide. 32 200+ INTELLECTUAL GRANTED PATENTS TRADEMARKS PROPERTY 50 30+ REGISTERED IN STATES COUNTRIES NASDAQ : TOMZ | Investor Presentation 2026
Slide 7: Market Opportunity - Start of Growth Journey
MARKET OPPORTUNITY - START OF GROWTH JOURNEY GLOBAL MARKET SIZES Global Market Sizes in USD Biotechnology Trillions 2025-2032 (source: grandviewresearch) • Expected to grow from $1.55 trillion in 2023 to $3.88 trillion by 2030 • CAGR of 13.96% Commercial Biotechnology Services $3.88T Food and Bevera
Slide 8: Markets
MARKETS Commercial Utilized in: Biotechnology Food & Beverage Healthcare Life Sciences Food Safety Services Manufacturing Hospitality Hospital Surface Decon Pharmaceutical Packaging Office Buildings Exam Room Area Decon Vivarium Processing Athletic Facility Hospice Mold Remediation Research Universi
Slide 9: SteraMist iHP Advantages
STERAMIST iHP ADVANTAGES TOMI’s Cold Plasma Science Elevates the Way a Six Log Kill is Achieved, It is Faster, Safer, Portable and less Caustic making SteraMist the perfect Decontaminate 10 out of 10! SIX-LOG & SUBMICRON GREATER PARTICLE SIZE RAPID KILL BROAD (5-SEC) EFFICACY SUPERIOR MATERIAL MOVES
Slide 10: Business Model
BUSINESS MODEL Equipment drives recurring BIT Solution consumables (high margin) INSTALLED BASE RECURRING BASE CONSUMABLES: +40% 1H 2025 vs. 1H 2024 GROSS MARGINS: ~60% NASDAQ : TOMZ | Investor Presentation 2026
Slide 11: SteraMist Integrated System Platform OEM Partners
STERAMIST INTEGRATED SYSTEM PLATFORM OEM PARTNERS Integrated Into: • Isolators • Material Transfers • Sterilizers • Hatches • Biosafety Cabinets • RABS These partnerships were put in place in 2024. Helping and building our $21M integration and build-in pipeline, shortening the sales cycle of our equ
Slide 12: Why SteraMist?
WHY STERAMIST? Start - Finish. Endless We Do it All. Markets. Demand. Consumable Preparedness Business Model. & Emergency. NASDAQ : TOMZ | Investor Presentation 2026
Slide 13: Product Overview
PRODUCT OVERVIEW Comprehensive range of SteraMist systems. Designed to meet the unique needs of every industry. Surface Spraying Systems Custom & Integrated Surface disinfection, 5-sec per square foot Fogging is enhanced and fully integrated. SteraPak SteraMist Hybrid Surface Unit Custom Engineered
Slide 14: SteraMist Systems
STERAMIST SYSTEMS SteraPak Surface Unit Standalone Transport NV+ Environment System SteraMist Hybrid SteraMist Integrated System Custom Engineered System NASDAQ : TOMZ | Investor Presentation 2026
Slide 15: Razor - Razor Blade Model
RAZOR - RAZOR BLADE MODEL BIT SOLUTION CONSUMABLE 32 OZ. 1 GALLON 5 GALLONS 55 GALLONS For use with the SteraPak For use with all other mobile For large volume & For use with the Custom system frequently treated areas Engineered System TOMI’s BIT Solution is central to our business model, delivering
Slide 16: From Concept to Commissioning
FROM CONCEPT TO COMMISSIONING DESI G NED I N -HO USE TO MI h an d les every step of the process —from the first concept in R& D to the final m anufactured design. DEPL O YED SERVIC E TO MI provi des 24/7 service for outbreak response and ongoi ng contracts. Q UAL I FI CATI O N & VAL ID ATI O N TO MI
Slide 17: Custom & Integrations
CUSTOM & INTEGRATIONS 2020 was the birth of the Hybrid, perfected in 2023, when interest spiked 2020-2021 Pitching closes 2022 2023 pitching closes for 2024/2025 development of SIS 2024 SIS launched 2025 mostly comprises SIS YTD shorter sales cycle, shorter design and manufacturing, size of the spac
Slide 18: Life Science Market
LIFE SCIENCE MARKET Regulatory tailwinds • Biosecurity • Shift Away from EtO (ethylene oxide) Expansions/upgrades at existing facilities. New plants to support biologics, mRNA, vaccines, and complex sterile products. Every six to eight years, Life Science companies replace their decontamination prod
Slide 19: Medical Sterilization Market
MEDICAL STERLIZATION MARKET SteraMist iHP: The Superior, Safe, and Scalable Alternative to Ethylene Oxide (EtO) Ethylene Oxide currently sterilizes ~50% of U.S. medical devices, but the industry is facing risk: Feature Ethylene Oxide (EtO) SteraMist (iHP) 14–24+ Hours (Long Cycle Time 45 Minutes or
Slide 20: Case Study: Philips
CASE STUDY PHILIPS The global medical device cleaning market was valued at approximately USD 23.78 billion in 2024 and is projected to reach around USD 56.12 billion by 2033, growing at a CAGR of about 10.01% during the forecast period. This growth is driven by increasing government initiatives and
Slide 21: Food Safety Market
FOOD SAFETY MARKET Stricter Regulations: Regulatory-driven adoption (FDA, FSMA, FSC) restricting Ethylene Oxide (EtO) • U.S. food facilities now require sanitation disinfection compliance. • Emphasis on reducing occupational exposure and emissions; stricter residue testing for finished products; pac
Slide 22: Case Studies: Nestlé and Egglife
CASE STUDIES NESTLÉ Current Clients: • Purchased a SteraPak in 2023 for Nestlé Purina Nestlé Purina Arizona: Quarter 3 2023 • Expanded into facilities around the world with our EU partner Nestlé Germany: Quarter 2 2024 • Working directly with Colombia and Brazil on future Nestlé Switzerland: Quarter
Slide 23: Healthcare Industry
HEALTHCARE INDUSTRY CHALLENGES: HAIs & SSIs Outbreaks Healthcare-associated infections Hospitals and long-term care facilities Lack of Resources Risk Strain on resources Risk to healthcare workers EXAMPLES • Influenza A • Klebsiella • Ebola C. diff affects ~500,000 • C. diff & C. auris annually in t
Slide 24: Case Study: Trinity Health Saint Francis Hospital
CASE STUDY TRINITY HEALTH SAINT FRANCIS HOSPITAL • One of the top hospitals in keeping Healthcare-Associated Infection (HAI) rates down. • C. difficle, MRSA, and central line-associated bloodstream infections at a minimum. • St. Francis quickly noticed a reduction in spores and was able to gain valu
Slide 25: Commercial Industry
COMMERCIAL INDUSTRY Enhanced Training Developed a program to provide on-demand training – SteraMist Pro Certified Biohazards & Environmental TOMI-certified trainers are needed to conduct onsite training Remediation for large service providers T.A.C.T. franchises brought on in Quarter 2, 2025 Assista
Slide 26: Revenue Growth
Revenue Growth + 38% REVENUE GROWTH Over Pre-Covid Levels • Indicating strong adoption by Tier 1 customers of a disruptive technology and long lead times, as current pipeline with integrated, mobile, and service at around $21M • Diversification of delivery systems achieved in 2024 with the introduct
Slide 27: Service & Support Expansion
SERVICE & SUPPORT EXPANSION iHP Corporate Service Dominance: Accounts for ~70–90% of total service revenue annually (e.g., $1.3M of $1.7M in 2024). Growth in Support: Support services surged to $203K (2025 to-date) vs. $105K in 2024, possibly indicating a strategic shift. Overall Stability: Services
Slide 28: Growth & Market Expansion
GROWTH & MARKET EXPANSION Sustainable Growth Drivers Pipeline • Focus on Year-over-Year (YoY) Growth to mitigate seasonal revenue fluctuations. • Past 18-Month Focus: Expanded product lines & services to address new applications of iHP SteraMist technology. Accelerating Momentum • Launched product/s
Slide 29: Clear Roadmap to Capitalize on Market Opportunity
CLEAR ROADMAP TO CAPITALIZE ON MARKET OPPORTUNITY: EXECUTION NOW PEOPLE STUDIES REGULATORY MARKETING Trainers: Sales Team: Hiring specialized training members to go onsite to the current Build a sales team that can capture demand. service provider network and developing personalized procedures to Ex
Slide 30: Growth Drivers & Pipeline
GROWTH DRIVERS & PIPELINE Pipeline ~$21.0M across products & services PIPELINE: $21.0M ACTIVE/SPECS/DESIGN: $7.0M 2026/2027 NEAR-TERM: $5M 2025 YTD BOOKINGS: $5M NASDAQ : TOMZ | Investor Presentation 2026
Slide 31: Increased Probability of Outbreaks, Epidemics and Pandemics
INCREASED PROBABILITY OF OUTBREAKS, EPIDEMICSAND PANDEMICS Disease: rapid spread through travel Restrictions: travel restrictions & border closures Impact: economic losses, disruption of global travel, reputational damager 10-FOLD INCREASE in the incidence of at least one of 13 44 Overall, the data
Slide 32: NASDAQ: TOMZ | Investor Presentation 2026
NASDAQ : TOMZ | Investor Presentation 2026
Slide 33: Thank You
NASDAQ:TOMZ Thank You We appreciate your time and consideration. Contact Us Visit Us Financial Resullts info@tomimist.com SteraMist.com investor.tomimist.com
TOMI Environmental Solutions — Q1 2026 Earnings Presentation on 6ix